Anhui HeartVoice Medical Technology Co., Ltd. is an AI medical technology enterprise. Its founding team comes from University of Science and Technology of China, Peking University and Huawei.
HeartVoice applies the new generation of AI technology such as deep learning to automatic analysis and diagnosis of electrocardiogram (ECG). HeartVoice is committed to reducing the cost of ECG diagnosis to less than 10% of the current situation of the industry with the accuracy comparable to human experts. HeartVoice was founded in 2017 and completed Angel round financing at the time of its establishment, with an estimated value of 50 million RMB.

intellectual property

问心无恙® is the AI ECG brand of Anhui xinzhisheng Medical Technology Co., Ltd., which contains a variety of ECG products. Heart health care is to protect human heart health with AI. Through the independent research and development of Cardio-learn® deep learning algorithm of the world's leading level by xinzhisheng, it carries ultra-thin chip to achieve automatic second level analysis and diagnosis of artificial intelligence ECG, and establishes big data of heart health through cloud service. It can realize real-time monitoring of heart health, and provide more families with the possibility of effective monitoring of heart health prevention.

Brand Vision

Caring for Human Heart Health with AI

intellectual property

15 invention patents have been published and verified, and 7 software copyrights and 1 design patent have been obtained

Honors won

Golden Award, China “Internet+” Innovation and Entrepreneurship Competition, 2019
Red Dot Design Award and Good Design Award, 2019
Second Place, the MedAI world AI Innovation Challenge ECG track
First Place, the 18th PhysioNet/Computing in Cardiology Challenge, 2017
Contact Us